排序
2023AHA科学声明:女性心血管疾病的危险因素—民族和种族的影响
CirculationAHA SCIENTIFIC STATEMENTCardiovascular Disease Risk Factors in Women:The Impact of Race and Ethnicity:A ScientificStatement From the American Heart AssociationLaxmi S.Me...
2023APSSM共识声明:阴茎重建和假体手术的临床建议
Sexual Medicine,2023,11,1-10https://doi.org/10.1093/sexmed/qfad003Society Report(S5MOXFORDClinical recommendations on penile reconstructive andprosthetic surgery:a consensus statem...
2023BSH指南:急性输血反应的调查与管理
Recetved:7 December 2022 Accepted:21 March 2023D0L:10.1111/bh.18789BJHaemGUIDELINEGuideline on the investigation and management of acutetransfusion reactionsRichard Soutar Wendy Mc...
2023EAS共识声明:纯合子家族性高胆固醇血症——新的治疗方法和临床指南(更新版)
ESCEuropean Heart Journal (2023)00,1-15SPECIAL ARTICLEEuropean Society https://doiorg/10.1093/eurheart/ehad197of CardiologyDyslipidaemias2023 Update on European AtherosclerosisSoci...
2023ESGO/ESHRE/ESGE指南:子宫内膜癌患者保留生育能力治疗
FACTS VIEWs VIs OBGYN.2023,15 (1):3-23shrepeen soaery tC WOVNESGE pagesESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatmentof patients with endometrial carcinoma*tA.RODOL...
2023HIS指南:急性和社区卫生以及社会护理机构诺如病毒病毒暴发的管理
ARTICLE IN PRESSJournal of Hospital Infection xxx (xxxx)xxxAvailable online at www.sciencedirect.comJournal of Hospital Infection..Healthcare:ELSEVIERjournal homepage:www.elsevier....
2023IWGDF指南:糖尿病足溃疡患者减荷(更新版)
Guidelines onoffloading foot ulcersin persons withdiabetes8518TUIWGDF 2023 updatePart of the 2023 IWGDF Guidelines onthe prevention and management ofdiabetes-related foot diseaseIW...
儿科感染性休克诊治进展
定义(一)感染性休克(septic shock),又称为败血症休克/脓毒性休克,是机体对病原体的炎症反应失控,引起循环和微循环功能紊乱,最终导致细胞代谢和脏器功能障碍的循环衰竭综合征。
HBVHCV相关性肝细胞癌抗病毒治疗专家建议【23页】
一、前言g乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染在肝细胞癌(HCC)的发生发展中起重要作用。·肝癌患者抗病毒治疗具有非常重要的意义·中华医学会肝病学分会肝癌学组按照循证医学的原测进行了...
2023NICE技术鉴定指导意见:曲妥珠单抗deruxtecan用于在1次或多次抗HER2治疗后治疗HER2阳性不可切除或转移性乳腺癌[TA862]
NENatonalinsutute forHealth and Care ExcellenceNICE贝guidanceTrastuzumab deruxtecanfor treating HER2-positiveunresectable or metastaticbreast cancer after 1 ormore anti-HER2treatme...



-bde1830360-pdf-1.webp)


-3386ceebe6-pdf-1.webp)


![2023NICE技术鉴定指导意见:曲妥珠单抗deruxtecan用于在1次或多次抗HER2治疗后治疗HER2阳性不可切除或转移性乳腺癌[TA862]-医知素材库](https://cdn.jiaoyuwz.com/2023NICE技术鉴定指导意见:曲妥珠单抗deruxtecan用于在1次或多次抗HER2治疗后治疗HER2阳性不可切除或转移性乳腺癌[TA862]-816b7b06b5-pdf-1.webp)
